Compare, Analyse SUVEN LIFE with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFESCIENCES vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SUVEN LIFESCIENCES   ACTAVIS
EQUITY SHARE DATA
    SUVEN LIFESCIENCES
Mar-19
ACTAVIS
Dec-18
SUVEN LIFESCIENCES/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs33814,313-   
Low Rs1699,601-   
Sales per share (Unadj.) Rs52.13,511.0-  
Earnings per share (Unadj.) Rs6.8-1,130.9-  
Cash flow per share (Unadj.) Rs8.6370.0-  
Dividends per share (Unadj.) Rs1.500-  
Dividend yield (eoy) %0.60-  
Book value per share (Unadj.) Rs65.314,481.3-  
Shares outstanding (eoy) m127.28332.60-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.93.4 142.8%   
Avg P/E ratio x37.1-10.6 -351.1%  
P/CF ratio (eoy) x29.632.3 91.5%  
Price / Book Value ratio x3.90.8 470.3%  
Dividend payout %22.00-   
Avg Mkt Cap Rs m32,2723,976,982 0.8%   
No. of employees `0001.116.9 6.4%   
Total wages/salary Rs m6610-   
Avg. sales/employee Rs Th6,132.269,098.5 8.9%   
Avg. wages/employee Rs Th611.10-   
Avg. net profit/employee Rs Th803.5-22,256.7 -3.6%   
INCOME DATA
Net Sales Rs m6,6351,167,764 0.6%  
Other income Rs m24222,332 1.1%   
Total revenues Rs m6,8771,190,096 0.6%   
Gross profit Rs m1,60430,601 5.2%  
Depreciation Rs m221499,194 0.0%   
Interest Rs m3867,387 0.1%   
Profit before tax Rs m1,587-513,648 -0.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0131,001 0.0%   
Tax Rs m718-6,509 -11.0%   
Profit after tax Rs m869-376,137 -0.2%  
Gross profit margin %24.22.6 922.6%  
Effective tax rate %45.21.3 3,569.1%   
Net profit margin %13.1-32.2 -40.7%  
BALANCE SHEET DATA
Current assets Rs m6,232478,956 1.3%   
Current liabilities Rs m1,490423,700 0.4%   
Net working cap to sales %71.54.7 1,510.5%  
Current ratio x4.21.1 370.0%  
Inventory Days Days8620 441.3%  
Debtors Days Days8366 124.6%  
Net fixed assets Rs m4,043132,184 3.1%   
Share capital Rs m1270-   
"Free" reserves Rs m8,1830-   
Net worth Rs m8,3104,816,483 0.2%   
Long term debt Rs m181,696,058 0.0%   
Total assets Rs m10,3897,529,258 0.1%  
Interest coverage x43.1-6.6 -650.9%   
Debt to equity ratio x00.4 0.6%  
Sales to assets ratio x0.60.2 411.8%   
Return on assets %8.7-4.1 -212.9%  
Return on equity %10.5-7.8 -134.0%  
Return on capital %19.5-4.8 -403.1%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m3,8220-   
CASH FLOW
From Operations Rs m356417,198 0.1%  
From Investments Rs m-279229,196 -0.1%  
From Financial Activity Rs m-225-716,037 0.0%  
Net Cashflow Rs m-148-69,295 0.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 73.97 Rs / USD

Compare SUVEN LIFESCIENCES With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare SUVEN LIFESCIENCES With: GSK PHARMA  ELDER PHARMA  ALEMBIC PHARMA  GLENMARK PHARMA  NATCO PHARMA  



Today's Market

4 Reasons Why Sensex Plunged 695 Points Today(Closing)

After opening the day on a positive note, Indian share markets witnessed heavy selling pressure during closing hours, pausing the record rally, following broad-based selling.

Related Views On News

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

SUVEN LIFESCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 22, 2019 | Updated on Jul 22, 2019

Here's an analysis of the annual report of SUVEN LIFESCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFESCIENCES. Also includes updates on the valuation of SUVEN LIFESCIENCES.

SUVEN LIFESCIENCES Announces Quarterly Results (4QFY19); Net Profit Up 8.7% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 680 m (up 8.7% YoY). Sales on the other hand came in at Rs 3 bn (up 18.5% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

More Views on News

Most Popular

This Diwali Consider Richa's #1 Stock Pick for 2021 (Profit Hunter)

Nov 13, 2020

Why I admire the approach that Richa uses to zero in on stocks with huge upside potential.

Don't Let Brokerages Fool You into Buying HUL & Nestle. The Real Money is in These Stocks Right Now... Views On News (Views On News)

Nov 12, 2020

Rahul Shah discusses why he preferred a little known stock over Nestle Ltd and how he was proven right.

How to Short Sell the Right Way (Fast Profits Daily)

Nov 13, 2020

In this video, I'll show you how to short sell effectively.

Stocks that Could Shine More than Gold After Diwali (Profit Hunter)

Nov 17, 2020

If the markets become volatile over the next few months, do this.

US Elections: Won a Battle, Now the War (The Honest Truth)

Nov 13, 2020

Ajit Dayal on the urgent need to fix the disparity between the rich and the poor in the US.

More
-->

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

SUVEN LIFESCIENCES SHARE PRICE


Nov 25, 2020 (Close)

TRACK SUVEN LIFESCIENCES

  • Track your investment in SUVEN LIFESCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN LIFESCIENCES

SUVEN LIFESCIENCES - BIOCON COMPARISON

COMPARE SUVEN LIFESCIENCES WITH

FEATURED VIDEOS

Is M&M the ITC of Auto Sector?

Don't Let Brokerages Fool You into Buying HUL & Nestle. The Real Money is in These Stocks Right Now...

What to Expect from Stocks during Covid Second Wave?

Rakesh Jhunjhunwala's Rs 500 Crore Bet on Tata Motors: A Sixer or a Hit-Wicket?

More Featured Videos

MARKET STATS